About

What this is

Every Monday, ResearchAlpha publishes the ten papers from the previous seven days most likely to affect a public company, ranked by a Market Sensitivity Score. Each entry says what the paper showed, why the market may care, and what event would resolve the question. The method is documented in full.

The intended reader already knows how to read a trial and wants the week compressed: which results are load-bearing, which company they touch, and what is still open. The point is the reasoning, not the ranking — every score is shown broken into its five components so it can be disagreed with.

Who writes it

ResearchAlpha is edited by a practicing neurosurgeon, writing anonymously. The anonymity is deliberate and permanent. Clinical work and public commentary on listed companies are better kept apart, and a named byline would invite the second to be read as speaking for the first. No name, institution, or location appears here or in the underlying repository.

Disclosures

• This is educational content. It is not investment advice and not a recommendation to buy or sell any security.
• The editor holds no positions in the companies covered and receives no compensation from them, their competitors, or their investors.
• Nothing here is sponsored. No company sees an issue before it is published.
• Papers are read as published. ResearchAlpha has no access to unpublished data, embargoed results, or company communications.
• Errors are corrected in place, with the correction noted rather than quietly folded in.

Following it

New issues appear on this site every Monday and in the RSS feed. There is no newsletter, no paywall, and no tracking.